4 minAntibody-drug conjugates in the treatment of uterine cancers: A promising therapeutic approachUterine cancers, which largely comprise endometrial cancer and uterine sarcoma, are a considerable health concern affecting women worldwide.
3 minLenvatinib plus pembrolizumab improved survival outcomes in advanced endometrial cancerUterine cancer is the second most prevalent Gynecological cancer in the world and it has high incidence rates in developed countries.
3 minDostarlimab receives approval as a revolutionary treatment in endometrial cancerEndometrial cancer, the most prevalent uterine cancer subtype, is the fourth most common cancer among women worldwide.